BJ
Beenu Jain
About Beenu Jain
Data last updated:
Beenu Jain is a Director at Glenford Pharmaceuticals Private Limited (since 2019), Director at Maxelder Pharma Private Limited (since 2022) and Director at Peelife Pharmaceuticals Private Limited (since 2023). The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹16.05 Cr; the largest is Glenford Pharmaceuticals Private Limited at ₹6.91 Cr (FY 2025). Earlier, Beenu Jain was a Director at Greenkind Bioscience Private Limited (from 2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Nov 2019 | 2019 | ₹6.91 Cr (FY 2025) | Active | |
| Director | 24 Oct 2022 | 2020 | ₹6.41 Cr (FY 2025) | Active | |
| Director | 05 May 2023 | 2012 | ₹2.73 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Sep 2020 | 2020 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Beenu Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mohit Saini | 06590261 | Glenford Pharmaceuticals Private Limited , Peelife Pharmaceuticals Private Limited | Director |
| Munish Kumar Jain | 03007925 | Glenford Pharmaceuticals Private Limited | Additional Director |
| Sanjay Chaturvedi | 09616204 | Maxelder Pharma Private Limited | Director |
| Ujjawal Garg | 09753918 | Peelife Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Beenu Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Beenu Jain
Beenu Jain currently holds 3 directorships: Glenford Pharmaceuticals Private Limited (Director, since 18 Nov 2019, revenue ₹6.91 Cr (FY 2025)); Maxelder Pharma Private Limited (Director, since 24 Oct 2022, revenue ₹6.41 Cr (FY 2025)); Peelife Pharmaceuticals Private Limited (Director, since 05 May 2023, revenue ₹2.73 Cr (FY 2025)).
Beenu Jain was first appointed on 18 Nov 2019 as Director at Glenford Pharmaceuticals Private Limited. The most recent appointment on record is 05 May 2023 at Peelife Pharmaceuticals Private Limited.
The 3 current companies of Beenu Jain that report revenue have a combined latest revenue of ₹16.05 Cr: Glenford Pharmaceuticals Private Limited ₹6.91 Cr (FY 2025); Maxelder Pharma Private Limited ₹6.41 Cr (FY 2025); Peelife Pharmaceuticals Private Limited ₹2.73 Cr (FY 2025).
Beenu Jain held 1 earlier board appointment: Greenkind Bioscience Private Limited (Director, from 04 Sep 2020).
The current boards of Beenu Jain's companies include Mohit Saini (Glenford Pharmaceuticals Private Limited), Munish Kumar Jain (Glenford Pharmaceuticals Private Limited), Sanjay Chaturvedi (Maxelder Pharma Private Limited), Ujjawal Garg (Peelife Pharmaceuticals Private Limited).